Table 3.

Utilization of Medical Therapies at discharge and at 1 year (by MPG)

	Discharge
	MPG 0/1 (N=30)		MPG 2/3 (N=109)		p-value
	N	%	N	%
Aspirin	29	96.7	108	99.1	0.39
Thienopyridines (clopidogrel or ticlopidine)	30	100.0	108	99.1	1.00
Aspirin or thienopyridine	30	100.0	109	100.0	NA
Aspirin plus thienopyridine	29	96.7	107	98.2	0.52
Warfarin	5	16.7	4	3.7	0.02
One or more of ASA, warfarin, thienopyridine	30	100.0	109	100.0	NA
Two or more of ASA, warfarin, thienopyridine	30	100.0	107	98.2	1.00
B-blocker	28	93.3	97	89.0	0.73
ACE inhibitor or ARB	29	96.7	94	86.2	0.19
Spironolactone	4	13.3	2	1.8	0.02
Lipid lowering agent	28	93.3	92	84.4	0.37
	1 year
	1 Year MPG 0 or 1 (N=29)		1 Year MPG 2 or 3 (N=106)		p-value
	N	%	N	%
Aspirin	28	96.6	100	94.3	1.00
Thienopyridine (clopidogrel)*	9	31.0	29	27.4	0.70
Aspirin or thienopyridine	28	96.6	103	97.2	1.00
Aspirin plus thienopyridine	9	31.0	26	24.5	0.48
B-blocker	28	96.6	89	84.0	0.12
ACE inhibitor or ARB	28	96.6	92	86.8	0.19
Spironolactone	4	13.8	6	5.7	0.22
Lipid lowering agent	28	96.6	93	87.7	0.30